Cited by 233Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

Johanson, Chris-Ellyn, Frey, Kirk A., Lundahl, Leslie H., Keenan, Pamela, Lockhart, Nancy, Roll, John, Galloway, Gantt P., Koeppe, Robert A., Kilbourn, Michael R., Robbins, Trevor, Schuster, Charles R.·2006·Psychopharmacology

DOI 10.1007/s00213-006-0330-6

Open this paper in CoChat — free account

Abstract

Objective Preclinical investigations have established that methamphetamine (MA) produces long-term changes in dopamine (DA) neurons in the striatum. Human studies have suggested similar effects and correlated motor and cognitive deficits. The present study was designed to further our understanding of changes in brain function in humans that might result from chronic high dose use of MA after at least 3 months of abstinence.Method Brain function in abstinent users was compared to controls using neuroimaging of monoamine transporters and cognitive assessment. Striatal levels of DA transporter (DAT) and vesicular monoamine transporter type-2 (VMAT2) were determined using [11C]methylphenidate and [11C]dihydrotetrabenazine positron emission tomography, respectively. Cognitive function was evaluated using tests of motor function, memory, learning, attention, and executive function.Results Striatal DAT was approximately 15% lower and VMAT2 was 10% lower in MA abusers across striatal subregions. The MA abusers performed within the normal range but performed more poorly compared to controls on three of the 12 tasks.Conclusions Failure to find more substantial changes in transporter levels and neurocognitive function may be attributed to the length of time that MA users were abstinent (ranging from 3 months to more than 10 years, mean 3 years), although there were no correlations with length of abstinence. Persistent VMAT2 reductions support the animal literature indicating a toxic effect of MA on nigrostriatal nerve terminals. However, the magnitude of the MA effects on nigrostriatal projection integrity is sufficiently small that it is questionable whether clinical signs of DA deficiency are likely to develop.

Integrity signals

Registry

Crossref · 10.1007/s00213-006-0330-6

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 8,167
Psychopharmacology: The third generation of progress
O’Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,020
Wechsler Adult Intelligence Scale--Third Edition
Wechsler, D. (2019) · PsycTESTS Dataset · doi:10.1037/t49755-000 · Cited by 2,327
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,021
Structured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Cambridge Neuropsychological Test Automated Battery (CANTAB): A Factor Analytic Study of a Large Sample of Normal Elderly Volunteers
Robbins, T. W., James, M., Owen, A. M., Sahakian, B. J., McInnes, L., & Rabbitt, P. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106735 · Cited by 1,078
Self-citation
Untitled work
(2001) · Medical Entomology and Zoology · Cited by 1,044
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Structural Abnormalities in the Brains of Human Subjects Who Use Methamphetamine
Thompson, P. M., Hayashi, K. M., Simon, S. L., Geaga, J. A., Hong, M., Sui, Y., Lee, J. Y., Toga, A. W., Ling, W. W., & London, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0713-04.2004 · Cited by 770
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754

Show all 49 references

Sorted by citations

Items 101–200 of 233

Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm
Henry, B. L., Minassian, A., van Rhenen, M., Young, J. W., Geyer, M. A., & Perry, W. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2170-2 · Cited by 36
A commentary on the effects of methamphetamine and the status of methamphetamine abuse among youths in South Korea, Japan, and China
Kwon, N. J., & Han, E. (2018) · Forensic Science International · doi:10.1016/j.forsciint.2018.02.022 · Cited by 36
Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects
Burke, S., van de Giessen, E., de Win, M. M. L., Schilt, T., van Herk, M., van den Brink, W., & Booij, J. (2010) · Psychological Medicine · doi:10.1017/s0033291710000486 · Cited by 35
Depression and alterations in hypothalamic–pituitary–adrenal and hypothalamic–pituitary–thyroid axis function in male abstinent methamphetamine abusers
Li, S., Yan, S., Bao, Y., Lian, Z., Qu, Z., Ya-ping, W., & Liu, Z. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2335 · Cited by 34
Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation
Lominac, K. D., McKenna, C. L., Schwartz, L. M., Ruiz, P. N., Wroten, M. G., Miller, B. W., Holloway, J. J., Travis, K. O., Rajasekar, G., Maliniak, D., et al. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00070 · Cited by 34
Neurobiology of Addiction
Urban, N., & Martínez, D. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.011 · Cited by 35
Degree of dependence influences the effect of smoking on cognitive flexibility
Nesic, J., Rusted, J. M., Duka, T., & Jackson, A. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.015 · Cited by 34
Neuroimaging and drug taking in primates
Murnane, K. S., & Howell, L. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2222-7 · Cited by 33
In vivo evidence for long-term CNS toxicity, associated with chronic binge use of methamphetamine
Chung, Y. A., Peterson, B. S., Yoon, S. J., Cho, S.-N., Chai, S., Jeong, J., & Kim, D. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.04.005 · Cited by 32
A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
Bowyer, J. F., Thomas, M., Patterson, T. A., George, N. I., Runnells, J. A., & Levi, M. S. (2012) · Journal of Visualized Experiments · doi:10.3791/4285 · Cited by 32
Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration
Aarde, S. M., & Taffe, M. A. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_54 · Cited by 31
Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings
Hou, H., Wang, C., Jia, S., Hu, S., & Tian, M. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-014-1469-5 · Cited by 33
Methamphetamine dependence with and without psychotic symptoms: A multi-modal brain imaging study
Vuletic, D., Dupont, P. J., Robertson, F. C., Warwick, J., Zeevaart, J. R., & Stein, D. J. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.10.023 · Cited by 29
Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline
Mahoney, J. J., Jackson, B. J., Kalechstein, A. D., Garza, R. D. L., & Newton, T. F. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.034 · Cited by 28
MAO-B inhibitor know-how
LeWitt, P. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a0feba · Cited by 28
The Impact of Clinical and Demographic Variables on Cognitive Performance in Methamphetamine-Dependent Individuals in Rural South Carolina
Price, K. L., DeSantis, S. M., Simpson, A. N., Tolliver, B. K., McRae‐Clark, A. L., Saladin, M. E., Baker, N. L., Wagner, M. T., & Brady, K. T. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00164.x · Cited by 27
Structural, Functional and Spectroscopic MRI Studies of Methamphetamine Addiction
Salo, R. E., & Fassbender, C. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_172 · Cited by 26
Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence
Boileau, I., McCluskey, T., Tong, J., Furukawa, Y., Houle, S., & Kish, S. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.267 · Cited by 24
Neuropsychological, impulsive personality, and cerebral oxygenation correlates of undergraduate polysubstance use
Hammers, D. B., & Suhr, J. A. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903379599 · Cited by 24
Effects of intranasal methamphetamine on metacognition of agency
Kirkpatrick, M. G., Metcalfe, J., Greene, M., & Hart, C. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1018-2 · Cited by 24
Elevated Neurobehavioral Symptoms Are Associated With Everyday Functioning Problems in Chronic Methamphetamine Users
Cattie, J. E., Woods, S. P., Iudicello, J. E., Posada, C., Grant, I., & The TMARC Group (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11080192 · Cited by 22
Neuropsychological Functioning among Chronic Khat Users in Jazan Region, Saudi Arabia
Ismail, A. A., Sanosy, R. M. E., Rohlman, D. S., & El‐Setouhy, M. (2013) · Substance Abuse · doi:10.1080/08897077.2013.832469 · Cited by 23
Aberrant Resting-State Cerebellar-Cerebral Functional Connectivity in Methamphetamine-Dependent Individuals After Six Months Abstinence
Li, X., Su, H., Zhong, N., Chen, T., Du, J., Ke, X., Xu, D., Song, W., Jiang, H., & Zhao, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00191 · Cited by 22
Alterations in the striatal dopamine system during intravenous methamphetamine exposure: Effects of contingent and noncontingent administration
Laćan, G., Hadamitzky, M., Kuczenski, R. T., & Melega, W. P. (2013) · Synapse · doi:10.1002/syn.21654 · Cited by 20
DOPAMINE D2 RECEPTOR STIMULATION INHIBITS ANGIOTENSIN II‐INDUCED HYPERTROPHY IN CULTURED NEONATAL RAT VENTRICULAR MYOCYTES
Li, H., Shi, S., Sun, Y., Zhao, Y., Li, Q., Li, H., Wang, R., & Xu, C. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05064.x · Cited by 20
Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling
Good, R. L., Liang, L., Patel, M., & Radcliffe, R. A. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.07.005 · Cited by 19
Neonatal (+)-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists
Graham, D. L., Amos‐Kroohs, R. M., Braun, A. A., Grace, C. E., Schaefer, T. L., Skelton, M. R., Williams, M. T., & Vorhees, C. V. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000144 · Cited by 19
Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study
Basedow, L. A., Kuitunen‐Paul, S., Wiedmann, M. F., Ehrlich, S., Roessner, V., & Golub, Y. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03169-3 · Cited by 18
Amphetamine-induced alteration to gaze parameters: A novel conceptual pathway and implications for naturalistic behavior
Hayley, A. C., Shiferaw, B. A., & Downey, L. A. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101929 · Cited by 18
Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways
Bourque, M., Dluzen, D. E., & Paolo, T. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.009 · Cited by 18
A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate
Thiruchselvam, T., Malik, S., & Foll, B. L. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1257633 · Cited by 19
Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice
Krasnova, I. N., Hodges, A. B., Ladenheim, B., Rhoades, R. E., Phillip, C. G., Ceseňa, A., Ivanova, E., Höhmann, C. F., & Cadet, J. L. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.06.007 · Cited by 18
Biochemical Neuroadaptations in the Rat Striatal Dopaminergic System after Prolonged Exposure to Methamphetamine Self-Administration
Jayanthi, S., Ladenheim, B., Sullivan, P., McCoy, M. T., Krasnova, I. N., Goldstein, D. S., & Cadet, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710092 · Cited by 17
Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine
Barker‐Haliski, M. L., Oldenburger, K., & Keefe, K. A. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12017 · Cited by 17
Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users
Ballard, M. E., Dean, A. C., Mandelkern, M. A., & London, E. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143510 · Cited by 17
COMT val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: preliminary findings
Saloner, R., Cherner, M., Sundermann, E. E., Watson, C. W., Iudicello, J. E., Letendre, S. L., Kumar, A. M., & Ellis, R. J. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113269 · Cited by 16
The implications of sleep disruption for cognitive and affective processing in methamphetamine abuse
Lipinska, G., Timol, R., & Thomas, K. G. F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.09.010 · Cited by 16
Clinical neuroscience of amphetamine-type stimulants
Courtney, K. E., & Ray, L. A. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.010 · Cited by 15
New perspectives on using brain imaging to study CNS stimulants
Lukas, S. E. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.011 · Cited by 15
Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons
Du, Y., Lee, Y. B., & Graves, S. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108817 · Cited by 15
Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors
Torres, D. J., Yorgason, J. T., Mitchell, C. C., Hagiwara, A., Andres, M. A., Kurokawa, S., Steffensen, S. C., & Bellinger, F. P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.631825 · Cited by 14
Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder
Khan, R., Turner, A., Berk, M., Walder, K. R., Rossell, S. L., Guerin, A. A., & Kim, J. H. (2025) · Biomolecules · doi:10.3390/biom15020306 · Cited by 15
Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity
Gross, N. B., Duncker, P. C., & Marshall, J. F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.014 · Cited by 13
Pharmacotherapy for Stimulant-Related Disorders
Haile, C. N., & Kosten, T. R. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0415-y · Cited by 13
Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities
Uhl, G. R. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.707 · Cited by 13
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study
Wang, T., Fan, T., Lappin, J., Li, X., Zhao, Y., Wu, P., Shi, J., Bao, Y., & Lü, L. (2021) · American Journal on Addictions · doi:10.1111/ajad.13209 · Cited by 12
Radioligands for Imaging Vesicular Monoamine Transporters
Kilbourn, M. R. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_27 · Cited by 12
Self-citation
Cannabis Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515.013 · Cited by 12
Climbing the Ladder with Gabriel
Sameshima, P., Vandermause, R. K., & Chalmers, S. (2009) · BRILL eBooks · doi:10.1163/9789087909918 · Cited by 12
Executive Dysfunction in Addiction
Jarmolowicz, D. P., Mueller, E. T., Koffarnus, M. N., Carter, A. E., Gatchalian, K. M., & Bickel, W. K. (2013) · Wiley eBooks · doi:10.1002/9781118384404.ch2 · Cited by 12
Effects of chronic aerobic exercise on attentional bias among women with methamphetamine addiction
Zhao, Q., Liu, J., Zhou, C., & Liu, T. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29847 · Cited by 11
The impact of methamphetamine use and dependence: A systematic review on the cognitive-behavioural implications for road safety
Love, S., Nicolls, M., Rowland, B., & Davey, J. D. (2024) · Transportation Research Part F Traffic Psychology and Behaviour · doi:10.1016/j.trf.2024.05.002 · Cited by 12
Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance
Saloner, R., Paolillo, E. W., Umlauf, A., Moore, D. J., Heaton, R. K., Grant, I., Cherner, M., & The TMARC Group (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617719000493 · Cited by 12
A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
Bowyer, J. F., Thomas, M., Patterson, T. A., George, N. I., Runnells, J. A., & Levi, M. S. (2012) · Journal of Visualized Experiments · doi:10.3791/4285-v · Cited by 11
Efficacy of the Marlatt cognitive-behavioral model on decreasing relapse and craving in women with methamphetamine dependence: A clinical trial
Abdoli, N., Farnia, V., Salemi, S., Tatari, F., Juibari, T. A., Alikhani, M., & Basanj, B. (2019) · Journal of Substance Use · doi:10.1080/14659891.2018.1549279 · Cited by 10
Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice
Pilski, A., & Graves, S. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713039 · Cited by 10
Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals
Kalechstein, A. D., Yoon, J. H., Croft, D. E., Jaeggi, S. M., Mahoney, J. J., & Garza, R. D. L. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.013 · Cited by 10
The time course of blood brain barrier leakage and its implications on the progression of methamphetamine-induced seizures
Bowyer, J. F., Tranter, K. M., Robinson, B. L., Hanig, J. P., Faubion, M. G., & Sarkar, S. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.09.008 · Cited by 10
The Pathology of Methamphetamine Use in the Human Brain
Kish, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00008-3 · Cited by 10
Differential profiles of cognitive and behavioral inflexibility in addictive disorders
Lim, T. V., & Ersche, K. D. (2024) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2024.101402 · Cited by 11
Association of Cognitive Impairment and Peripheral Inflammation in Methamphetamine-dependent Patients: A Cross-sectional Study on Neuroinflammatory Markers TNF-α and IL-6
Permpoonputtana, K., Namyen, J., Buntup, D., Boontem, P., Nopparat, C., & Govitrapong, P. (2025) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1236 · Cited by 9
Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity
Schrantee, A., & Reneman, L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.029 · Cited by 9
Methamphetamine Addiction, Treatment, and Outcomes: Implications for Child Welfare Workers
Otero, C., Boles, S. M., Young, N. L., & Dennis, K. (2006) · Lincoln (University of Nebraska) · Cited by 9
Associations between methamphetamine use disorder and SLC18A1 , SLC18A2 , BDNF , and FAAH gene sequence variants and expression levels
Guerin, A. A., Spolding, B., Bozaoglu, K., Swinton, C., Liu, Z. S.-J., Panizzutti, B., Truong, T. T. T., Dean, B., Lawrence, A. J., Bonomo, Y. A., et al. (2024) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2024.2413476 · Cited by 8
Neuroimaging of Dopamine Transporter Density in the Striatum of Disordered Gamblers
Guerra, R. F., Batista, I. R., Kim, H. S. A., Hoexter, M. Q., Shih, M. C., Bressan, R. A., & Tavares, H. (2022) · Journal of Gambling Studies · doi:10.1007/s10899-021-10100-8 · Cited by 8
Mindfulness-Based Intervention on Chinese Patients with Amphetamine-Type Stimulant Use Disorders: an EEG Functional Connectivity Study
Zhang, J., Chen, T., Tan, H., Wu, Q., Chen, L., Yuan, C., Ding, X., Zhang, L., Du, C., Li, J., et al. (2022) · Mindfulness · doi:10.1007/s12671-022-01882-y · Cited by 8
Therapeutic targeting of neuroinflammation in methamphetamine use disorder
Jeffery, N., Mock, P. Y., Yang, K., Tham, C. L., Israf, D. A., Li, H., Wang, X., & Lam, K. W. (2024) · Future Medicinal Chemistry · doi:10.1080/17568919.2024.2447226 · Cited by 7
Substance Use Disorders
Duncan, P. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139025515 · Cited by 8
Neurodegeneration from Drugs and Aging‐Derived Free Radicals
Ramkissoon, A., Shapiro, A. M., Loniewska, M. M., & Wells, P. G. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch10 · Cited by 6
ERK-Directed Phosphorylation of mGlu5 Gates Methamphetamine Reward and Reinforcement in Mouse
Fultz, E. K., Quadir, S. G., Martin, D. L., Flaherty, D. M., Worley, P. F., Kippin, T. E., & Szumlinski, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031473 · Cited by 5
Crystal-Meth als Herausforderung für das Suchthilfesystem – Klinische Empfehlungen
Härtel-Petri, R. (2015) · Suchttherapie · doi:10.1055/s-0035-1559657 · Cited by 5
The modern trends in alcohol, drugs and driving research
Raes, E., Pil, K., & Verstraete, A. (2009) · Forensic science international supplement series · doi:10.1016/j.fsisup.2009.07.004 · Cited by 5
Improved Response Inhibition Through Cognition-Guided EEG Neurofeedback in Men With Methamphetamine Use Disorder
Gou, H., Bu, J., Cheng, Y. F., Liu, C., Gan, H., Liu, M., Zhao, Q., Chen, X., Ren, J., Hong, W., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240475 · Cited by 4
Long‐term effects of methamphetamine abuse on visual evoked potentials
Mahjoob, M., & Heydarian, S. (2022) · Ophthalmic and Physiological Optics · doi:10.1111/opo.13048 · Cited by 4
A comparative study of the effects of methamphetamine on memory in existing and recovering addicts from a South African population
van Wyk, C., & Stuart, A. D. (2012) · Health SA Gesondheid · doi:10.4102/hsag.v17i1.607 · Cited by 4
Neurochemical Imaging of Addictive Disorders
Broft, A. I., & Martínez, D. (2012) · Neuromethods · doi:10.1007/7657_2012_48 · Cited by 4
Bias Toward Drug-Related Stimuli Is Affected by Loading Working Memory in Abstinent Ex-Methamphetamine Users
Deldar, Z., Ekhtiari, H., Pouretemad, H. R., & Khatibi, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00776 · Cited by 4
Does Chronic Methamphetamine Use Result in a Consistent Profile of Cognitive Deficits
Chong, J. A. (2009) · CommonKnowledge Research Repository (Pacific University Oregon) · Cited by 3
Psychostimulants
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816990-2.00001-6 · Cited by 4
Fries, lies and alibis: the impact of methamphetamine use on moral values and moral conduct
Bax, T. M. (2024) · Kōtuitui New Zealand Journal of Social Sciences Online · doi:10.1080/1177083x.2024.2314493 · Cited by 3
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese
Asser, A., Kõks, S., Snellman, A., Haaparanta‐Solin, M., Arponen, E., Grönroos, T. J., Nairismägi, J., Bergquist, J., Soomets, U., Piip, P., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.09.034 · Cited by 3
PET Imaging of Vesicular Monoamine Transporters
Kilbourn, M. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_33 · Cited by 3
Self-citation
Abnormalities of Neurotransmission in Drug Addiction
Trick, L., Butler, K., Chukwueke, C. C., Ciano, P. D., Ibrahim, C., Rubin-Kahana, D. S., Boileau, I., & Foll, B. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_21 · Cited by 4
Isradipine, an L-type calcium channel inhibitor, attenuates cue-associated methamphetamine-seeking in mice
Choi, S., Methiwala, H. N., & Graves, S. M. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148528 · Cited by 2
Working Memory and Long-Term Abstinence from Substance Use
Jasper, L. E. (2016) · Digital Commons - George Fox University (George Fox University) · Cited by 2
Amphetamine-induced neurite injury in PC12 cells through inhibiting GAP-43 pathway
Yan, X., He, W., & Pan, S. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.09.004 · Cited by 2
Neuropathologic Features in Chronic Methamphetamine Use
Persons, J. E., & Conway, K. S. (2023) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000817 · Cited by 3
Substance Use Disorders: Cognitive Sequelae, Behavioral Manifestations, Neuroimaging Correlates, and Novel Interventions
Mahoney, J. J., Bryant, K. R., & Haut, M. W. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_32 · Cited by 2
An Integrated Framework for Human Neuroimaging Studies of Addiction from a Preclinical Perspective
Ersche, K. D., & Robbins, T. W. (2011) · Wiley eBooks · doi:10.1002/9781119998938.ch2 · Cited by 2
Self-citation
Desempeño cognitivo en usuarios y no usuarios de metanfetaminas en abstinencia temprana y prolongada
Ruiz, P. A. F., Gomar, M. L. G., Cortés, A. N., Cruz-Zúñiga, N., & Chávez-Méndez, J. R. (2023) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2023.2.06 · Cited by 1
Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research
Johansen, A. N., Smith, M. A., & Stoops, W. W. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100145 · Cited by 1
Neurochemical Imaging in Addiction
Wai, J. M., LEVIN, F. R., & Martínez, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00001-8 · Cited by 1
Molecular Imaging Studies in Stimulant Addiction: A Cross-Species Perspective
Jones, J. A., Russell, B., & Dalley, J. W. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_22 · Cited by 1
Addiction-induced cognitive impairment, the case of methamphetamine
Ruiz, P. A. F., Cruz-Zúñiga, N., Vergara, C. I. H., Martínez-Alvarado, J. R., Chávez-Flores, Y. V., & Magallanes-Rodríguez, A. G. (2023) · Horizon Interdisciplinary Journal · doi:10.56935/hij.v1i2.18 · Cited by 1
Substance Use Disorders: A Biopsychosocial Perspective
Duncan, P. M. (2020) · ODU Digital Commons (Old Dominion University) · Cited by 1
Positron Emission Tomography of the Reward System
Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · Neuromethods · doi:10.1007/978-1-0716-1146-3_14 · Cited by 1
Models of Methamphetamine-Induced Neurotoxicity
Gibson, A. S., & Keefe, K. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_190-1 · Cited by 1
Developmental Disorders of Attention
Cohen, R. A. (2013) · Springer eBooks · doi:10.1007/978-0-387-72639-7_18 · Cited by 1
The Effect of Early Life Stress on Methamphetamine Damage in the Striatum
Hensleigh, E. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/5836111
Methamphetamine withdrawal: clinical profile, assessment and treatment
Cruickshank, C. (2010) · UWA Profiles and Research Repository (UWA)

Authors: Johanson, C.-E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., Galloway, G. P., Koeppe, R. A., Kilbourn, M. R., Robbins, T., & Schuster, C. R.
Affiliations: Wayne State University (US)
University of Michigan (US)
Friends Research Institute (US)
University of Cambridge (GB)
Corresponding author: Johanson, Chris-Ellyn
ORCID: Frey, Kirk A.
Lundahl, Leslie H.
Lockhart, Nancy
Roll, John
Koeppe, Robert A.
Kilbourn, Michael R.
Robbins, Trevor
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2006-03-03
Volume: 185
Issue: 3
Pages: 327-338
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-006-0330-6
OpenAlex: W1973774749
Cited by: 233
References: 49
Citations by year: 2026: 2 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 11 · 2020: 30 · 2019: 8 · 2018: 9 · 2017: 12 · 2016: 11 · 2015: 15 · 2014: 12 · 2013: 19 · 2012: 21
FWCI: 4.40
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Deep Blue (University of Michigan) (submittedVersion)
Funders: National Institutes of Health (5r01da012458-03, 5r21da014392-02)
National Institute on Drug Abuse (DA14392, DA12458, R01DA010641, R01 DA10641)
National Institute of Neurological Disorders and Stroke (NS-15655)
National Center for Research Resources (RR00042, M01RR000042)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords: methamphetamine, abstinence, cognitive function, nigrostriatal pathway, dopamine transporter, vesicular monoamine transporter 2, striatum, dopamine deficiency, monoamine transporters, executive function, learning and memory, attention, motor function
MeSH terms: Adolescent, Adult, Cognition, Corpus Striatum, Dopamine, Female, Humans, Male, Methamphetamine, Middle Aged, Psychological Tests, Substantia Nigra, Amphetamine-Related Disorders, Dopamine Plasma Membrane Transport Proteins, Vesicular Monoamine Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks